Cargando…

Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain

Breastfeeding mothers were excluded from the clinical trials conducted for vaccines against SARS-CoV-2. Since the start of the vaccination, some doubts have arisen regarding its compatibility with breastfeeding. The aim of this study was to analyse the presence of anti-SARS-CoV-2 antibodies in breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Lechosa-Muñiz, Carolina, Paz-Zulueta, María, Mendez-Legaza, Jose Manuel, Irure-Ventura, Juan, Cuesta González, Rocío, Calvo Montes, Jorge, López-Hoyos, Marcos, Llorca, Javier, Cabero-Pérez, María Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393848/
https://www.ncbi.nlm.nih.gov/pubmed/34444579
http://dx.doi.org/10.3390/ijerph18168831
_version_ 1783743817813327872
author Lechosa-Muñiz, Carolina
Paz-Zulueta, María
Mendez-Legaza, Jose Manuel
Irure-Ventura, Juan
Cuesta González, Rocío
Calvo Montes, Jorge
López-Hoyos, Marcos
Llorca, Javier
Cabero-Pérez, María Jesús
author_facet Lechosa-Muñiz, Carolina
Paz-Zulueta, María
Mendez-Legaza, Jose Manuel
Irure-Ventura, Juan
Cuesta González, Rocío
Calvo Montes, Jorge
López-Hoyos, Marcos
Llorca, Javier
Cabero-Pérez, María Jesús
author_sort Lechosa-Muñiz, Carolina
collection PubMed
description Breastfeeding mothers were excluded from the clinical trials conducted for vaccines against SARS-CoV-2. Since the start of the vaccination, some doubts have arisen regarding its compatibility with breastfeeding. The aim of this study was to analyse the presence of anti-SARS-CoV-2 antibodies in breast milk and serum (IgG and IgA) of vaccinated breastfeeding women. The main variables of the observational study were: adverse related events after vaccination and determination of the presence of IgG and IgA isotypes antibodies in serum and in breast milk of vaccinated women against the SARS-CoV-2 antigens. Results: 110 breastfeeding mothers were included; 70 women (63.6%) were vaccinated with two doses of BNT162b2, 20 women (18.2%) with two doses of mRNA-1273, and 20 women (18.2%) with a single dose of ChAdOx1-S. Regarding adverse reactions and vaccine safety, 38 women had no adverse reactions; 20 (18.2%) had general malaise or adenopathies; 10 (9.1%) had a headache; and 7 (6.4%) had fever. When analysing IgG antibodies, significantly higher levels of antibodies were found in serum and breast milk from mothers vaccinated with BNT162b2 or mRNA-1273 vs. ChAdOx1-S (p < 0.001 and p = 0.001, respectively). Analysing IgA antibodies, significant differences were found when comparing mean values in serum from mothers vaccinated with BNT162b2 or mRNA-1273 vs. ChAdOx1-S (0.12, 0.16, and 0.02, respectively; p < 0.001) and breast milk of mothers vaccinated when comparing BNT16b2 vs. ChAdOx1-S. All vaccinated breastfeeding mothers had serum anti-S1 IgG antibodies in response to vaccination against SARS-CoV-2, regardless of the commercial vaccine administered. Conclusions: the anti-SARS-CoV-2 vaccines were well tolerated by the mothers and the breastfed infant. In addition, breastfeeding mothers offer their infants IgA and IgG isotype antibodies directed against SARS-CoV-2 protein S in breast milk.
format Online
Article
Text
id pubmed-8393848
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83938482021-08-28 Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain Lechosa-Muñiz, Carolina Paz-Zulueta, María Mendez-Legaza, Jose Manuel Irure-Ventura, Juan Cuesta González, Rocío Calvo Montes, Jorge López-Hoyos, Marcos Llorca, Javier Cabero-Pérez, María Jesús Int J Environ Res Public Health Article Breastfeeding mothers were excluded from the clinical trials conducted for vaccines against SARS-CoV-2. Since the start of the vaccination, some doubts have arisen regarding its compatibility with breastfeeding. The aim of this study was to analyse the presence of anti-SARS-CoV-2 antibodies in breast milk and serum (IgG and IgA) of vaccinated breastfeeding women. The main variables of the observational study were: adverse related events after vaccination and determination of the presence of IgG and IgA isotypes antibodies in serum and in breast milk of vaccinated women against the SARS-CoV-2 antigens. Results: 110 breastfeeding mothers were included; 70 women (63.6%) were vaccinated with two doses of BNT162b2, 20 women (18.2%) with two doses of mRNA-1273, and 20 women (18.2%) with a single dose of ChAdOx1-S. Regarding adverse reactions and vaccine safety, 38 women had no adverse reactions; 20 (18.2%) had general malaise or adenopathies; 10 (9.1%) had a headache; and 7 (6.4%) had fever. When analysing IgG antibodies, significantly higher levels of antibodies were found in serum and breast milk from mothers vaccinated with BNT162b2 or mRNA-1273 vs. ChAdOx1-S (p < 0.001 and p = 0.001, respectively). Analysing IgA antibodies, significant differences were found when comparing mean values in serum from mothers vaccinated with BNT162b2 or mRNA-1273 vs. ChAdOx1-S (0.12, 0.16, and 0.02, respectively; p < 0.001) and breast milk of mothers vaccinated when comparing BNT16b2 vs. ChAdOx1-S. All vaccinated breastfeeding mothers had serum anti-S1 IgG antibodies in response to vaccination against SARS-CoV-2, regardless of the commercial vaccine administered. Conclusions: the anti-SARS-CoV-2 vaccines were well tolerated by the mothers and the breastfed infant. In addition, breastfeeding mothers offer their infants IgA and IgG isotype antibodies directed against SARS-CoV-2 protein S in breast milk. MDPI 2021-08-21 /pmc/articles/PMC8393848/ /pubmed/34444579 http://dx.doi.org/10.3390/ijerph18168831 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lechosa-Muñiz, Carolina
Paz-Zulueta, María
Mendez-Legaza, Jose Manuel
Irure-Ventura, Juan
Cuesta González, Rocío
Calvo Montes, Jorge
López-Hoyos, Marcos
Llorca, Javier
Cabero-Pérez, María Jesús
Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain
title Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain
title_full Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain
title_fullStr Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain
title_full_unstemmed Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain
title_short Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain
title_sort induction of sars-cov-2-specific igg and iga in serum and milk with different sars-cov-2 vaccines in breastfeeding women: a cross-sectional study in northern spain
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393848/
https://www.ncbi.nlm.nih.gov/pubmed/34444579
http://dx.doi.org/10.3390/ijerph18168831
work_keys_str_mv AT lechosamunizcarolina inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain
AT pazzuluetamaria inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain
AT mendezlegazajosemanuel inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain
AT irureventurajuan inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain
AT cuestagonzalezrocio inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain
AT calvomontesjorge inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain
AT lopezhoyosmarcos inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain
AT llorcajavier inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain
AT caberoperezmariajesus inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain